Nyxoah (NYXH) Projected to Post Earnings on Tuesday

Nyxoah (NASDAQ:NYXH - Get Free Report) is anticipated to announce its earnings results before the market opens on Tuesday, March 4th. Analysts expect the company to announce earnings of ($0.48) per share for the quarter.

Nyxoah Stock Performance

Shares of NYXH traded down $0.21 during midday trading on Friday, reaching $10.04. The stock had a trading volume of 40,467 shares, compared to its average volume of 44,127. The company has a current ratio of 5.28, a quick ratio of 4.95 and a debt-to-equity ratio of 0.21. The firm has a 50 day simple moving average of $9.89 and a 200-day simple moving average of $9.04. The firm has a market cap of $341.96 million, a PE ratio of -5.37 and a beta of 1.40. Nyxoah has a one year low of $6.76 and a one year high of $20.00.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on NYXH. Cantor Fitzgerald reissued an "overweight" rating and set a $16.00 price target on shares of Nyxoah in a research report on Tuesday, November 5th. HC Wainwright reissued a "buy" rating and set a $17.00 target price on shares of Nyxoah in a report on Friday, December 13th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $17.00.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.